Dianthus Therapeutics, Inc. /DE/ Variable Lease, Cost
Dianthus Therapeutics, Inc. /DE/ (DNTH) reported Variable Lease, Cost of $11.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-04
- Dianthus Therapeutics, Inc. /DE/ variable lease, cost for the quarter ending 2026-06-30 was $11.00K, a 22.22% increase year-over-year.
- Dianthus Therapeutics, Inc. /DE/ variable lease, cost for the quarter ending 2026-03-31 was $9.00K, a 25.00% decline year-over-year.
- Dianthus Therapeutics, Inc. /DE/ variable lease, cost for the quarter ending 2025-12-31 was $11.00K, a 10.00% increase year-over-year.
- Dianthus Therapeutics, Inc. /DE/ variable lease, cost for the quarter ending 2025-09-30 was $12.00K, a 71.43% increase year-over-year.
- Dianthus Therapeutics, Inc. /DE/ variable lease, cost for fiscal 2025 was $44.00K, a 37.50% increase from fiscal 2024.
- Dianthus Therapeutics, Inc. /DE/ variable lease, cost for fiscal 2024 was $32.00K, a 14.29% increase from fiscal 2023.
- Dianthus Therapeutics, Inc. /DE/ variable lease, cost for fiscal 2023 was $28.00K, a 600.00% increase from fiscal 2022.
- Dianthus Therapeutics, Inc. /DE/ variable lease, cost for fiscal 2022 was $4.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 3 month as first filed | Variable Lease, Cost 6 month | Variable Lease, Cost 6 month as first filed | Variable Lease, Cost 9 month | Variable Lease, Cost 9 month as first filed | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $11.00K 10-Q · filed 2026-08-04 | $20.00K 10-Q · filed 2026-08-04 | $31.00K derived: sum of 3 quarters · filed 2026-08-04 | $43.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $9.00K 10-Q · filed 2026-05-05 | $20.00K derived: sum of 2 quarters · filed 2026-05-05 | $32.00K derived: sum of 3 quarters · filed 2026-05-05 | $41.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $23.00K derived: sum of 2 quarters · filed 2026-03-09 | $32.00K derived: sum of 3 quarters · filed 2026-08-04 | $44.00K 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $12.00K 10-Q · filed 2025-11-05 | $21.00K derived: sum of 2 quarters · filed 2026-08-04 | $33.00K 10-Q · filed 2025-11-05 | $43.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $9.00K 10-Q · filed 2026-08-04 | $21.00K 10-Q · filed 2026-08-04 | $31.00K derived: sum of 3 quarters · filed 2026-08-04 | $38.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $12.00K 10-Q · filed 2026-05-05 | $22.00K derived: sum of 2 quarters · filed 2026-05-05 | $29.00K derived: sum of 3 quarters · filed 2026-05-05 | $36.00K derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $17.00K derived: sum of 2 quarters · filed 2026-03-09 | $24.00K derived: sum of 3 quarters · filed 2026-03-09 | $32.00K 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $7.00K 10-Q · filed 2025-11-05 | $14.00K derived: sum of 2 quarters · filed 2025-11-05 | $22.00K 10-Q · filed 2025-11-05 | $30.00K derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | $7.00K 10-Q · filed 2025-08-07 | $15.00K 10-Q · filed 2025-08-07 | $23.00K derived: sum of 3 quarters · filed 2025-08-07 | $30.00K derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $8.00K 10-Q · filed 2025-05-12 | $16.00K derived: sum of 2 quarters · filed 2025-05-12 | $23.00K derived: sum of 3 quarters · filed 2025-05-12 | $29.00K derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $15.00K derived: sum of 2 quarters · filed 2025-03-11 | $21.00K derived: sum of 3 quarters · filed 2025-03-11 | $28.00K 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | $7.00K 10-Q · filed 2024-11-07 | $13.00K derived: sum of 2 quarters · filed 2024-11-07 | $20.00K 10-Q · filed 2024-11-07 | $20.00K derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $6.00K 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2023-08-03 | $13.00K 10-Q · filed 2024-08-08 | $491.00K 10-Q · filed 2023-08-03 | $13.00K derived: sum of 3 quarters · filed 2024-08-08 | $14.00K derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $7.00K 10-Q · filed 2024-05-09 | $491.00K 10-Q · filed 2023-05-15 | $7.00K derived: sum of 2 quarters · filed 2024-05-09 | $8.00K derived: sum of 3 quarters · filed 2024-05-09 | $12.00K derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $1.00K derived: sum of 2 quarters · filed 2024-03-21 | $5.00K derived: sum of 3 quarters · filed 2024-03-21 | $4.00K 10-K · filed 2024-03-21 | $1.41M 10-K · filed 2023-03-23 | |||
| 2022-09-30 | $1.00K 10-Q · filed 2023-11-09 | $441.00K 10-Q · filed 2022-11-03 | $5.00K derived: sum of 2 quarters · filed 2023-11-09 | $4.00K 10-Q · filed 2023-11-09 | $951.00K 10-Q · filed 2022-11-03 | |||
| 2022-06-30 | $4.00K 10-Q · filed 2023-08-03 | $510.00K 10-Q · filed 2023-08-03 | ||||||
| 2022-03-31 | $506.00K 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | $0.00 8-K · filed 2023-12-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |